Stockreport

CEL-SCI Reports Fiscal First Quarter 2026 Results

Cel-Sci Corporation  (CVM) 
NASDAQ:AMEX Investor Relations: cel-sci.com/investor_relations.html
PDF Set to Commence Patient Enrollment Summer of 2026 in Pivotal U.S. FDA Head and Neck Cancer Registration StudyEntering Saudi Oncology Market, Potentially Through Key Part [Read more]